Safety and Efficacy of Odronextamab in Patients With Relapsed or Refractory Follicular Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
Ann. Oncol 2024 Aug 13;[EPub Ahead of Print], TM Kim, M Taszner, S Novelli, SG Cho, JC Villasboas, M Merli, AJ Ubieto, B Tessoulin, LM Poon, D Tucker, J Walewski, S Yi, Y Song, G Chong, E Bachy, S Guidez, A Alonso, D Jagadeesh, W Zhang, L Magnano, E Iskierka-Jażdżewska, M Tani, B Shen, A Uppala, M Zhu, S Shariff, J Brouwer-Visser, A Chaudhry, H Mohamed, S Ambati, S LuminariFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.